At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed Jun 4, 2026 at 16:01 ET
Syndax Pharmaceuticals granted inducement awards for 66,700 shares to four new employees under the 2023 Inducement Plan. The stock options vest over four years with a one-year cliff. This is a routine compensation event with no material impact on the company's financials or operations.
- Inducement awards granted on June 1, 2026
- 66,700 shares of common stock awarded to four new employees
- Options vest over four years with 25% after one year and monthly thereafter
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access